Correlation Between Eli Lilly and MiMedx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and MiMedx Group, you can compare the effects of market volatilities on Eli Lilly and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and MiMedx.

Diversification Opportunities for Eli Lilly and MiMedx

-0.85
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eli and MiMedx is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Eli Lilly i.e., Eli Lilly and MiMedx go up and down completely randomly.

Pair Corralation between Eli Lilly and MiMedx

Considering the 90-day investment horizon Eli Lilly and is expected to under-perform the MiMedx. But the stock apears to be less risky and, when comparing its historical volatility, Eli Lilly and is 2.26 times less risky than MiMedx. The stock trades about -0.12 of its potential returns per unit of risk. The MiMedx Group is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  618.00  in MiMedx Group on September 18, 2024 and sell it today you would earn a total of  298.00  from holding MiMedx Group or generate 48.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  MiMedx Group

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
MiMedx Group 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MiMedx Group are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, MiMedx reported solid returns over the last few months and may actually be approaching a breakup point.

Eli Lilly and MiMedx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and MiMedx

The main advantage of trading using opposite Eli Lilly and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.
The idea behind Eli Lilly and and MiMedx Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data